Quantitative assessment of the relevance of organic-anion-transporting-polypeptide 1B1 and 2B1 polymorphisms in fexofenadine pharmacokinetic variants via pharmacometrics.

Authors:
Jang JH; Jeong SH; Lee YB.

Journal:
J Pharm Anal

Publication Year: 2023

DOI:
10.1016/j.jpha.2023.04.001

PMCID:
PMC10334346

PMID:
37440913

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Pharm Anal

Abbreviation: J Pharm Anal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A chiral metal-organic framework {(HQA)(ZnCl<sub>2</sub>)(2.5H<sub>2</sub>O)}<sub>n</sub> for the e…
Zheng X; Zhang Q; Ma Q and 3 more (2023) - Transparency Score: 3/6
A proteomic landscape of pharmacologic perturbations for functional relevance.
Liu Z; Jiang S; Hao B and 8 more (2023) - Transparency Score: 3/6
A robust luminescent assay for screening alkyladenine DNA glycosylase inhibitors to overcome DNA re…
Song YQ; Li GD; Niu D and 5 more (2023) - Transparency Score: 3/6
Benzodiazepines in complex biological matrices: Recent updates on pretreatment and detection method…
Zhang YX; Zhang Y; Bian Y and 5 more (2023) - Transparency Score: 3/6
Biosensors for waterborne virus detection: Challenges and strategies.
Song X; Fredj Z; Zheng Y and 4 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025